Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorReig-Viader, Rita
dc.contributor.authorGiménez-García, Emmanuel
dc.date.accessioned2020-02-19T10:12:06Z
dc.date.available2020-02-19T10:12:06Z
dc.date.issued2019
dc.identifier.citationReig-Viader R, Giménez E. MALDI-TOF en el diagnóstico de las resistencias a antibióticos. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya; 2019. (Informes, estudios e investigación).
dc.identifier.other731-19-057-8
dc.identifier.urihttp://hdl.handle.net/11351/4656
dc.descriptionMALDI-TOF; Mass spectrometry technology; Diagnosis; Infectious disease
dc.description.abstractIn any infectious disease, the administration of a suitable antibiotic treatment in the appropriate and necessary moment is key for the care and evolution of the patient, and also to reduce its morbimortality. Because of that, it is determining that the diagnostic and treatment of the disease were carried out as soon as possible. The increasing incidence of caused infections for resistant pathogens (or multiresistant) to the available antibiotics provokes a high probability of error in its treatment. For instance it happens in the cases of severe infections, the treatment of which, because of being urgent, is usually chosen empirically, without expecting the outcomes of sensitivity. In fact, it is estimated that the choice of the antibiotic, the indications and the duration of the treatment for the infectious diseases are erroneous in 30-50% of the cases. This not only it drives to an increase of the morbimortality of these diseases, but, still more important, it promotes the appearance and dissemination of antimicrobic resistances among the pathogenic microorganisms. Precisely, the high error rate in the treatment of the infectious diseases, together with the uncontrolled use of antibiotics in the last decades has caused that today there is an alarming number of resistant pathogens and, consequently, an increase of the incidence of infectious diseases of difficult treatment and the mortality associated with these ones. Therefore, it is preferential to adopt measures that allow to revert and to control this situation.
dc.language.isospa
dc.publisherAgència de Qualitat i Avaluació Sanitàries de Catalunya
dc.publisherMinisterio de Sanidad, Consumo y Bienestar Social
dc.relation.ispartofseriesInformes, estudios e investigación;
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectEspectrometria de masses
dc.subjectInfecció - Diagnòstic
dc.subjectResistència als medicaments
dc.subject.meshMass Spectrometry
dc.subject.meshInfection
dc.subject.mesh/diagnosis
dc.subject.meshDrug Resistance, Bacterial
dc.titleMALDI-TOF en el diagnóstico de las resistencias a antibióticos
dc.title.alternativeMALDI-TOF mass spectrometry technology in the diagnosis of antibiotic resistance
dc.typeinfo:eu-repo/semantics/report
dc.subject.decsespectrometría de masas
dc.subject.decsinfección
dc.subject.decs/diagnóstico
dc.subject.decsfarmacorresistencia bacteriana
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliationAgència de Qualitat i Avaluació Sanitàries de Catalunya (AQUAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record